Literature DB >> 1334635

Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma.

M A Gerber1, Y S Shieh, K S Shim, S N Thung, A J Demetris, M Schwartz, G Akyol, S Dash.   

Abstract

Several serologic studies suggest that infection by hepatitis C virus (HCV) may be associated with the development of hepatocellular carcinoma (HCC). Therefore, we examined tumor tissue and/or the surrounding liver of 20 patients for viral sequences by the polymerase chain reaction (PCR). In 12 cases, liver and tumor tissues were separable for extraction. RNA was extracted from frozen tissues and used as a template for reverse transcription followed by double PCR with nested primers for the 5'-untranslated (NT) and nonstructural NS3 regions of HCV. In addition, the tissue extracts were tested by single PCR for X gene and S gene sequences of hepatitis B virus (HBV). NT region sequences of HCV were detected in the available tumor tissue of all anti-HCV-positive patients except for one. Negative (replicative) strands of HCV RNA were found in the same tissues as positive (genomic) strands at almost the same relative amounts, suggesting replication of HCV in the tumor tissue rather than contamination by HCV-positive blood. HBV X and S sequences were demonstrated in two tumors, but were absent from three tumors that were surrounded by liver tissues with HBV X sequences. One patient had nucleic acids of both viruses in tumor tissue. These observations suggest that in addition to HBV, HCV may play a role in the development of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334635      PMCID: PMC1886767     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

Authors:  P Farci; H J Alter; D Wong; R H Miller; J W Shih; B Jett; R H Purcell
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

2.  Hepatitis B virus infection in patients with idiopathic liver disease.

Authors:  T J Liang; Y Baruch; E Ben-Porath; R Enat; L Bassan; N V Brown; N Rimon; H E Blum; J R Wands
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

3.  Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

Authors:  M C Yu; M J Tong; P Coursaget; R K Ross; S Govindarajan; B E Henderson
Journal:  J Natl Cancer Inst       Date:  1990-06-20       Impact factor: 13.506

4.  Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.

Authors:  J H Han; V Shyamala; K H Richman; M J Brauer; B Irvine; M S Urdea; P Tekamp-Olson; G Kuo; Q L Choo; M Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

5.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

Authors:  N Ogata; H J Alter; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.

Authors:  A M Di Bisceglie; S E Order; J L Klein; J G Waggoner; M H Sjogren; G Kuo; M Houghton; Q L Choo; J H Hoofnagle
Journal:  Am J Gastroenterol       Date:  1991-03       Impact factor: 10.864

7.  Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease.

Authors:  B Nalpas; F Driss; S Pol; B Hamelin; C Housset; C Brechot; P Berthelot
Journal:  J Hepatol       Date:  1991-01       Impact factor: 25.083

8.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

9.  Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology.

Authors:  F Negro; D Pacchioni; Y Shimizu; R H Miller; G Bussolati; R H Purcell; F Bonino
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  12 in total

1.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.

Authors:  M J Tong; L P Lai; K Murakami-Mori
Journal:  West J Med       Date:  1997-08

Review 3.  Viruses and hepatocellular carcinoma.

Authors:  S Sherlock
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

4.  Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.

Authors:  Djamila Harouaka; Ronald E Engle; Kurt Wollenberg; Giacomo Diaz; Ashley B Tice; Fausto Zamboni; Sugantha Govindarajan; Harvey Alter; David E Kleiner; Patrizia Farci
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

5.  Association between hepatitis C and hepatocellular carcinoma.

Authors:  Luis Jesuino de Oliveria Andrade; Argemiro D'Oliveira; Rosangela Carvalho Melo; Emmanuel Conrado De Souza; Carolina Alves Costa Silva; Raymundo Paraná
Journal:  J Glob Infect Dis       Date:  2009-01

6.  Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers.

Authors:  S Tanaka; K Takenaka; T Matsumata; R Mori; K Sugimachi
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

7.  Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients.

Authors:  D Sansonno; A R Iacobelli; V Cornacchiulo; G Iodice; F Dammacco
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

8.  Hepatitis C virus replication in hepatocellular carcinoma.

Authors:  J Niu; U Kumar; J Monjardino; R Goldin; D Rosin; H C Thomas
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

9.  Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.

Authors:  Partha K Chandra; Feyza Gunduz; Sidhartha Hazari; Ramazan Kurt; Rajesh Panigrahi; Bret Poat; David Bruce; Ari J Cohen; Humberto E Bohorquez; Humberto E Behorquez; Ian Carmody; George Loss; Luis A Balart; Tong Wu; Srikanta Dash
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

10.  Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

Authors:  S Kubo; S Nishiguchi; T Shuto; H Tanaka; T Tsukamoto; K Hirohashi; T Ikebe; K Wakasa; T Kuroki; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1999-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.